Attention Laurel Patients:  Effective, Tues May 28th, the new Laurel office is open. The address is 7140 Contee Road, Suite 3500, Laurel, MD 20707……  Attention  Annapolis Patients: The One Community in Care event will be held on June 8th from 11am-2pm in the Annapolis parking lot.

Trial Protocol ID USOR 22187_D926XC00001_TROPION

Trial Description

A Phase 3 Open-Label, Randomised Study of Datopotamab Deruxtecan (Dato-Dxd) with or without Durvalumab versus Investigator’s Choice of Therapy in Patients with Stage I-III Triple-Negative Breast Cancer who have Residual Invasive Disease in the Breast and/or Axillary Lymph Nodes at Surgical Resection Following Neoadjuvant Systemic Therapy (TROPION-Breast03)

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Disease Types

Sponsor

  • AstraZeneca

ClinicalTrials.gov NCT ID

  • NCT05629585